Company announcement 12/2020
Excellis is a leading specialized global provider in end-to-end supply chain consulting services to the life sciences industry. With the acquisition of Excellis, NNIT strengthens its leading global position within life sciences even further.
Excellis will strengthen NNIT’s customer portfolio across the global pharma and biotech industries and enhance the Group’s ability to provide end-to-end life sciences IT services to all customers.
Per Kogut, CEO of NNIT, comments:
“We are excited to welcome Excellis and their unique experience and expert knowledge of the life sciences end-to-end supply chain. The acquisition is an important milestone in our strategy to grow the life sciences segment, further. At the same time, we are delivering on our promise to further strengthen and grow our portfolio of IT services and solutions to the benefit of our customers. Excellis will play an important role in securing our leading global position.”
“We are extremely proud to join the
Transaction overview
NNIT will acquire 100% of the shares of Excellis for an upfront payment of
Following the acquisition, Excellis will in daily operations continue its current business, while working together with NNIT on new and existing business opportunities. Excellis will be named “Excellis Health Solutions - an NNIT Group Company”.
NNIT will finance the acquisition through its operating cash flows and existing credit facilities. No external equity or debt financing will be needed.
Closing of the agreement is expected to be during November, 2020.
Strategic rationale
The combination of pharma production IT winning solutions and Excellis’ supply chain expertise strengthens NNIT’s international deliveries and helps secure new manufacturing execution systems (MES) implementation and
Additionally, NNIT can integrate information from manufacturing processes with information from the supply chain, providing clients with an increased overview and control over the supply chain.
Excellis’ unique position as the only global reselling and implementation partner of
Further, NNIT and Excellis can collaborate to offer end-to-end MS Dynamics and SAP S/4 Hana services, from vendor selection and advisory to implementation and application outsourcing as well as supporting Excellis’s customers in adapting the wide range of Veeva Solutions offerings.
About Excellis
Headquartered in
For the financial year 2020, Excellis is expected to generate revenue of around
Outlook
The acquisition is expected to generate additional revenue in the last two months of 2020 of around
As a result, the outlook for 2020 in constant currencies is increased:
- Revenue growth around -7.5% in constant currencies, while expected growth excluding Excellis is maintained at around -8% in constant currencies
- Operating profit margin before special items of around 6% in constant currencies is maintained
- Level of investment (CAPEX) is 5-7% of total revenue is maintained excluding the acquisition of Excellis
Contacts for further information
Investor relations: Media relations:
Jens Binger Tina Joanne Hindsbo
Head of Investor Relations NNIT Communications
Tel: +45 3079 9222 Tel: +45 3077 9578
jblb@nnit.com tnjh@nnit.com
About NNIT
Attachment
- 12 20201109 Company announcement Acquisition of Excellis Health Solutions_v1
© OMX, source